UNSPSC 51472601: Amylmetacresol

This classification denotes a topical anti-infective agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 05W904P57F. European Medicines Agency schedules Amylmetacresol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05497MIG. Amylmetacresol generally arises in the molecular formula C12H18O.

UNSPSC 51472601 Amylmetacresol is a Commodity code covering antiseptic throat lozenges and related oral care products procured by state and local government health facilities, fire departments, and multi-agency cooperative purchasing consortia. The code captures consumable pharmaceutical and over-the-counter products distributed through state procurement systems and authorized pharmaceutical wholesalers to support operational needs across government agencies. State and local issuing bodies procuring under this code include county boards of commissioners, state departments of administration overseeing multi-state cooperative purchasing alliances, and fire rescue departments sourcing janitorial and operational supplies that may include throat lozenges and similar consumables.

Recent activity shows two representative solicitations: Hillsborough County Board of County Commissioners issued ITB2600319 on July 7, 2026 for consumable janitorial and operational supplies to support the Hillsborough County Fire Rescue Department's 47 fire stations, with bids due July 24, 2026 and an estimated contract value of $765,679.84 for a one-year period; and the Minnesota Department of Administration's Office of State Procurement issued an RFP through the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) on January 20, 2026 for generic multi-source pharmaceuticals and over-the-counter products across participating state and local government facilities including Oregon, with proposals due March 26, 2026 and effectiveness planned for July 1, 2026. Geographic spread includes Florida (Hillsborough County) and Minnesota administering multi-state cooperative purchasing. Vendors must meet FDA compliance, cGMP certification, and Drug Supply Chain Security Act requirements, maintain relationships with authorized pharmaceutical wholesalers, and comply with administrative fee structures and performance penalty provisions.